Testosterone and prostate cancer: revisiting old paradigms.
about
Androgens and prostate diseaseTransversal European survey on testosterone deficiency diagnosis.Low pretreatment serum total testosterone is associated with a high incidence of Gleason score 8-10 disease in prostatectomy specimens: data from ethnic Chinese patients with localized prostate cancer.Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancerProstate size and adverse pathologic features in men undergoing radical prostatectomyThe role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2.Current state of practice regarding testosterone supplementation therapy in men with prostate cancerPreoperative Serum Sex Hormone-Binding Globulin Level Is an Independent Predictor of Biochemical Outcome After Radical Prostatectomy.Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomyPubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.Molecular pathogenesis and progression of prostate cancerStable Intraprostatic Dihydrotestosterone in Healthy Medically Castrate Men Treated With Exogenous Testosterone.Androgen regulation of prostate cancer: where are we now?Targeting the androgen receptor signalling axis in castration-resistant prostate cancer (CRPC).Serum testosterone level, testosterone replacement treatment, and prostate cancer.Phytoandrogenic properties of Eurycoma longifolia as natural alternative to testosterone replacement therapy.Update on Testosterone Replacement Therapy in Hypogonadal Men.Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.Second to fourth digit ratio, adult testosterone level and testosterone deficiency.Racial Differences in Age-Related Variations of Testosterone Levels Among US Males: Potential Implications for Prostate Cancer and Personalized Medication.Serum testosterone levels, testis volume, and the risk of prostate cancer: are these factors related?Low free and bioavailable testosterone levels may predict pathologically-proven high-risk prostate cancer: a prospective, clinical trial.Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml.The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.Preoperative circulating sex hormones are not predictors of positive surgical margins at open radical prostatectomy.Preoperative sex steroids are significant predictors of early biochemical recurrence after radical prostatectomy.Low serum testosterone is a predictor of high-grade disease in patients with prostate cancer.Additional value of the ratio of serum total testosterone to total prostate-specific antigen in the diagnosis of prostate cancer in a Chinese population.Low testosterone levels are related to poor prognosis factors in men with prostate cancer prior to treatment.Study of testosterone as a predictor of tumor aggressiveness in patients with prostate cancer.Preoperative hypogonadism is not an independent predictor of high-risk disease in patients undergoing radical prostatectomy.Testosterone Levels Correlate With Grade Group 5 Prostate Cancer: Another Step Toward Personalized Medicine.The effect of testosterone treatment on prostate histology and apoptosis in men with late-onset hypogonadism.Regucalcin is an androgen-target gene in the rat prostate modulating cell-cycle and apoptotic pathways
P2860
Q27010093-7DDC703D-71B2-44B6-B6E1-CBDD6A8DE890Q30318156-F9156953-DB8F-4771-8989-0A3A1CC7A0EEQ30565173-FDE26275-1FE6-40CD-A7EB-9586FAD47F63Q33599365-29BDD0ED-9137-4C93-BB28-5219BA04D6FBQ33827201-53000616-73C7-445F-89EB-6E782A9FD374Q34097510-F7A9DEB9-4B11-4E68-8BD5-7D5BB9FD4777Q34293663-F44EF1AA-156E-47FB-BE8F-CEAF8DADF9E7Q36196628-14671F6E-D161-4898-8ACD-DE1EBC1FD013Q36530243-CE384B03-65B5-4687-A937-463717F36877Q36765569-E7A6C9E7-53CC-464B-B6AC-221AC23FE0A1Q37055715-CEB75FF5-36DE-4DA2-B456-9ADDDBD2DC6CQ37057953-7AABE07C-1B71-491F-9328-FD39CF47D583Q37836264-6A61DF8C-BDAD-45E5-8D1B-D1604CF1240DQ38044064-41BE283D-1866-4C68-9E93-60A1B4F9E2D4Q38155496-219D6E1C-03E7-4D9B-9B3C-6F721A68DC10Q38175427-B7B790E4-17A6-4FD6-91D6-485707547E62Q38528376-7E90E6A9-1FCD-4E53-AE40-94159C70F844Q38592105-22EAC42A-1A26-4282-A2F6-8DE9AF22C12EQ39983639-ACE95C38-9CA1-43B4-86F4-2D4B452CE693Q40008016-05D4C824-2AE1-4B2E-A9BB-169CE2F047BDQ40309735-2678513C-E138-4C0A-BD1D-4B4AC1F94395Q40501272-312F5EFE-FE21-45E3-89E1-DC5B39AC176CQ41650121-B165ADBC-9A37-49F9-99EB-0EA02371C9BEQ42035769-93574138-8AFD-4F66-BE69-3CFF71B272F5Q42617082-221813E6-2EEB-4BFA-9B81-16553BA91B2DQ46990159-AC339FA7-42FC-415A-97F8-98C99E0BAA1FQ47700604-BDFD6949-89AE-4F33-9B72-0E3D9FB34AA2Q48331261-DCD0BA05-A745-4F09-BF4A-A241D450C0F1Q48573622-A791F5C6-4E6A-4CF7-A456-F64686F5821EQ50985557-A463A268-9F06-4FFB-9AD2-0A916A6128C1Q51052297-2F41EF12-1F57-424C-A54B-1EC1822B8496Q52996349-126BB7FF-4DEA-470A-91EA-71A9E70AC27EQ53160861-2D4CBF19-8C58-4794-9E56-D67971B2BDCAQ59152983-E02FB1E9-F008-4AD5-B348-5024EBFC3495
P2860
Testosterone and prostate cancer: revisiting old paradigms.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Testosterone and prostate cancer: revisiting old paradigms.
@en
Testosterone and prostate cancer: revisiting old paradigms.
@nl
type
label
Testosterone and prostate cancer: revisiting old paradigms.
@en
Testosterone and prostate cancer: revisiting old paradigms.
@nl
prefLabel
Testosterone and prostate cancer: revisiting old paradigms.
@en
Testosterone and prostate cancer: revisiting old paradigms.
@nl
P2093
P1433
P1476
Testosterone and prostate cancer: revisiting old paradigms.
@en
P2093
Abraham Morgentaler
Alvaro Morales
Claude Schulman
Hendrik Isbarn
Jehonathan H Pinthus
Leonard S Marks
P356
10.1016/J.EURURO.2009.03.088
P407
P577
2009-04-08T00:00:00Z